Discussions also delved into the complexities of value-based oncology care, the growing role of real-world data, and strategies to improve access to care in hematology. Across all sessions, a common ...

Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated positive overall survival results.

It’s clear the growth rate for oncology products is slowing. Figure 1 Global Oncology Sales and Growth Considering this moderating growth, IMS conducted an Oncology Launch Excellence Study to ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

For its part, IBM has said that the Watson for Oncology product has been improving year-on-year as the AI crunches more and more data. That is backed up by a meta analysis of its performance ...

This dynamic landscape has driven the creation of a range of immune checkpoint-related products, encompassing high-quality proteins, inhibitor screening kits, stable cell lines, and PK assay kits.

A lot of the products we use to treat redness and rosacea are similar, however, so while those on this list are formulated for skin with rosacea, they can also help skin that’s prone to redness.

After hours: January 29 at 4:32:09 PM EST Loading Chart for CTOR ...

A protein dataset from the HPV genome was curated by the company and is in the process of detecting cytotoxic T-cell (CTL) targets for a trial of Tevogen’s first oncology product candidate, TVGN 920.